The mouse study showed that the number of mice developing pulmonary metastases 4 weeks after the tumor cell injection was significantly lower in the PAK1‐shRNA group (1 out 10 mice) relative to the scrambled control group (6 out of 10 mice) (Fig. 5A). The gene discussed is PAK1; the disease is neoplasm.